Department of Sciences and Technology, HAWK University of Applied Sciences and Arts, Von-Ossietzky-Str. 99, 37085 Göttingen, Germany; PVZ - Center of Pharmaceutical Engineering, Technische Universität Braunschweig, Franz-Liszt-Str. 35a, 38106 Braunschweig, Germany.
Department of Sciences and Technology, HAWK University of Applied Sciences and Arts, Von-Ossietzky-Str. 99, 37085 Göttingen, Germany; Fraunhofer IST, Application Center for Plasma and Photonics, Von-Ossietzky-Str. 100, 37085 Göttingen, Germany.
Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1513-1523. doi: 10.1016/j.bbagen.2019.05.014. Epub 2019 May 23.
In recent years, the medical use of cold atmospheric plasma has received much attention. Plasma sources can be suited for widely different indications depending on their physical and chemical characteristics. Being interested in the enhancement of drug transport across the skin by plasma treatment, we evaluated three dielectric barrier discharges (DBDs) as to their potential use in permeabilizing human isolated stratum corneum (SC).
Imaging techniques (electrochemical and redox-chemical imaging, fluorescence microscopy), transepithelial electrical resistance measurements and permeation studies were employed to study the permeabilizing effect of different DBD-treatments on SC.
Filamentous μs-pulsed DBDs induced robust pore formation in SC. Increasing the power of the μs-pulsed DBD lead to more pronounced pore formation but might increase the risk of undesired side-effects. Plasma permeabilization was much smaller for the ns-pulsed DBD, which left SC samples largely intact.
The comparison of different DBDs provided insight into the mechanism of DBD-induced SC permeabilization. It also illustrated the need to tailor electrical characteristics of a DBD to optimize it for a particular treatment modality. For future applications in drug delivery it would be beneficial to monitor the permeabilization during a plasma treatment.
Our results provide mechanistic insight into the potential of an emerging interdisciplinary technology - plasma medicine - as a prospective tool or treatment option. While it might become a safe and pain-free method to enhance skin permeation of drug substances, this is also a mechanism to keep in mind when tailoring plasma sources for other uses.
近年来,冷大气压等离子体在医学中的应用受到了广泛关注。根据其物理和化学特性,等离子体源可以适用于广泛不同的适应症。我们对等离子体处理增强药物经皮传输的作用很感兴趣,因此评估了三种介质阻挡放电(DBD)作为潜在的用于使人体分离的角质层(SC)通透的方法。
采用电化学和氧化还原化学成像、荧光显微镜、跨上皮电阻测量和渗透研究来研究不同 DBD 处理对 SC 通透性的影响。
丝状 μs 脉冲 DBD 在 SC 中诱导出强烈的孔形成。增加 μs 脉冲 DBD 的功率会导致更明显的孔形成,但可能会增加不良副作用的风险。ns 脉冲 DBD 的等离子体通透性要小得多,它使 SC 样本基本保持完整。
不同 DBD 的比较深入了解了 DBD 诱导 SC 通透性的机制。它还说明了需要根据特定的治疗模式来调整 DBD 的电气特性,以对其进行优化。对于未来在药物输送中的应用,在等离子体处理过程中监测通透性将是有益的。
我们的结果为新兴的跨学科技术 - 等离子体医学 - 作为一种有前途的工具或治疗选择提供了机制上的见解。虽然它可能成为一种安全无痛的方法来增强药物物质的皮肤渗透,但这也是在为其他用途定制等离子体源时需要记住的一种机制。